Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment
Abstract Best1 and Best2 are two members of the bestrophin family of anion channels critically involved in the prevention of retinal degeneration and maintenance of intraocular pressure, respectively. Here, we solved glutamate- and γ-aminobutyric acid (GABA)-bound Best2 structures, which delineate a...
Saved in:
| Main Authors: | Aaron P. Owji, Jingyun Dong, Alec Kittredge, Jiali Wang, Yu Zhang, Tingting Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54938-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bestrophin-4 relays HES4 and interacts with TWIST1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells
by: Zijing Wang, et al.
Published: (2024-12-01) -
Systematic analysis of molecular mechanisms of action of essential macro- and micronutrients on the neurotransmitter and vasodilator molecule nitric oxide (NO)
by: O. A. Gromova, et al.
Published: (2025-01-01) -
Preferential allosteric modulation of Otop1 channels by small molecule compounds
by: Xiangjin Kong, et al.
Published: (2025-02-01) -
Predicting patent challenges for small-molecule drugs: A cross-sectional study.
by: Ally Memedovich, et al.
Published: (2025-02-01) -
Identification of druggable binding sites and small molecules as modulators of TMC1
by: Pedro De-la-Torre, et al.
Published: (2025-05-01)